He trained as a medical doctor in Syria and did a PhD at Cambridge in order to set up a cancer research unit in Aleppo. In 2012, Dr Talal Al-Mayhani found himself in an impossible situation and decided to settle in the UK. He has worked hard for peace in Syria ever since – and is convinced that it will come. When it does, he will return to Aleppo.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
Scientists have discovered a new way to generate human motor nerve cells in a development that will help research into motor neurone disease.
A Cambridge University researcher investigating eye cell transplants in the battle against glaucoma has been awarded £200,000 by the Fight for Sight charity.
New treatments for glaucoma are a key priority in vision research. Advances in stem cell technology in Cambridge are helping to make this dream a reality.
The way a common virus hijacks the cell it infects could hold the clue to combating Parkinson's disease.
© 2024 University of Cambridge